Carl Byrnes
Stock Analyst at Northland Capital Markets
(2.46)
# 2,507
Out of 5,046 analysts
25
Total ratings
55.56%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $29.01 | +89.59% | 1 | Sep 3, 2025 | |
| BWAY BrainsWay | Maintains: Outperform | $15 → $19 | $16.89 | +12.49% | 4 | Aug 14, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $27.92 | +11.03% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.75 | +163.16% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $2.13 | +181.69% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.81 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $16.22 | +54.13% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $4.04 | +5,840.59% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $21.75 | +267.82% | 4 | Aug 17, 2022 | |
| MDXG MiMedx Group | Initiates: Outperform | $23 | $7.65 | +200.65% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $2.97 | +708.08% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.27 | +88,005.73% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.16 | - | 1 | Sep 27, 2017 |
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $29.01
Upside: +89.59%
BrainsWay
Aug 14, 2025
Maintains: Outperform
Price Target: $15 → $19
Current: $16.89
Upside: +12.49%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $27.92
Upside: +11.03%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.75
Upside: +163.16%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $2.13
Upside: +181.69%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.81
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $16.22
Upside: +54.13%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $4.04
Upside: +5,840.59%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $21.75
Upside: +267.82%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $7.65
Upside: +200.65%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $2.97
Upside: +708.08%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.27
Upside: +88,005.73%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.16
Upside: -